Evidence map›Paper›PMID 37503348›Full record

ArticleFrontiers in immunology2023

Case Report: Resolution of Lichen Planus Pemphigoides as an unexpected outcome of SARS-CoV-2 infection.

Valentina Ruffo di Calabria, Alice Verdelli, Lavinia Quintarelli, Alberto Corrà, Elena Biancamaria Mariotti, Cristina Aimo, Elena Del Bianco, Beatrice Bianchi, Vincenza Maio, Daniela Massi and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. A Case Report of Tislelizumab-Induced Lichen Planus Pemphigoides.Clinical, cosmetic and investigational dermatology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Valentina Ruffo di CalabriaSection of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
Alice VerdelliRare Skin Diseases Unit, Department of Health Sciences, Azienda USL Toscana Centro (ERN-SKIN), University of Florence, Florence, Italy.
Lavinia QuintarelliRare Skin Diseases Unit, Department of Health Sciences, Azienda USL Toscana Centro (ERN-SKIN), University of Florence, Florence, Italy.
Alberto CorràSection of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
Elena Biancamaria MariottiSection of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
Cristina AimoSection of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
Elena Del BiancoSection of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
Beatrice BianchiSection of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
Vincenza MaioSection of Anatomic Pathology, Azienda USL Toscana Centro, Florence, Italy.
Daniela MassiSection of Anatomic Pathology, Department of Health Sciences, University of Florence, Florence, Italy.
Marzia CaproniRare Skin Diseases Unit, Department of Health Sciences, Azienda USL Toscana Centro (ERN-SKIN), University of Florence, Florence, Italy.
University of Florence · ITAzienda Usl Toscana Centro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is well known that viral infections play a relevant role in inducing or protecting from autoimmune diseases, thus representing a major environmental factor in the disruption of the immune system in genetically susceptible individuals. Since the beginning of the Covid-19 pandemic a great number of clinical and epidemiological studies have demonstrated that SARS-CoV-2 infection is no exception to the rule by interfering on many different levels in the normal functioning of our immune system. Even though a growing number of case series and case reports has been cited in the literature linking the infection to the new onset of autoimmune diseases, to date very little has been reported concerning a possible correlation between the virus and the clinical resolution of any kind of autoimmune pathology. Here we describe an interesting case of abrupt and unexpected resolution of Lichen planus pemphigoides mucocutaneous lesions in a fully vaccinated patient after a mildly symptomatic SARS-CoV-2 respiratory infection and we speculate on the possible underlying mechanisms correlating the two events.

Indexed as

Autoimmune DiseasesCOVID-19Lichen PlanusHumansPandemicsSARS-CoV-2autoimmunityCOVID-19Lichen planus pemphigoidesmolecular mechanismsSARS-CoV-2viral infections

Identifiers

PMID37503348
PMCPMC10368974
OpenAlexW4384008313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.